HOUSE_OVERSIGHT_020901.jpg

1.78 MB
View Original

Extraction Summary

0
People
7
Organizations
1
Locations
2
Events
0
Relationships
4
Quotes

Document Information

Type: Presentation slides / financial analysis report
File Size: 1.78 MB
Summary

This document consists of two presentation slides (pages 119 and 120) from a KPCB 'USA Inc.' report. The first slide analyzes historical Medicare spending, noting that actual 1990 costs ($110B) were significantly higher than the 1967 estimates ($12B). The second slide contrasts this with Medicare Part D (2006-2009), which cost 45% less than projected ($61B vs $111B) due to lower participation and private sector management. The document bears a 'HOUSE_OVERSIGHT_020901' Bates stamp, indicating it was part of a document production for a congressional investigation.

Organizations (7)

Name Type Context
KPCB
Logo and URL present on slides
House Ways & Means Committee
Cited as making spending estimates in 1967
Senate Joint Economic Committee
Source for data on slide 119
The Washington Times
Quoted regarding Medicare Part D costs
Morgan Stanley Healthcare Research
Source for data on slide 120
USA Inc.
Name of the presentation/report series
House Oversight Committee
Implied by the Bates stamp 'HOUSE_OVERSIGHT'

Timeline (2 events)

1967
House Ways & Means Committee estimated spending increases
USA
2010-08-16
The Washington Times published a statement regarding Medicare Part D costs
USA

Locations (1)

Location Context
USA
Subject of the report 'USA Inc.'

Key Quotes (4)

"If History is a Guide, There is Potential for Estimates to Understate Eventual Costs – Medicare Is 10x Higher Than Spending Forecast"
Source
HOUSE_OVERSIGHT_020901.jpg
Quote #1
"In reality, total spending increased 61.1x"
Source
HOUSE_OVERSIGHT_020901.jpg
Quote #2
"However, More Recent Healthcare Entitlement Such as Medicare part D Has Cost Less Than Expected"
Source
HOUSE_OVERSIGHT_020901.jpg
Quote #3
"The Washington Times stated on August 16th 2010 – "The lower cost - a result of slowing demand for prescription drugs, higher use of generic drugs and fewer people signing up - has surprised even some of the law's most pessimistic critics.""
Source
HOUSE_OVERSIGHT_020901.jpg
Quote #4

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document